Mesenchymal Stem Cells Market 2015-2022 - Global Strategic Business Report 2016 - Development of Regenerative Medicine Accelerates Demand for MSCs - Research and Markets - Seite 3

• JCR Pharmaceuticals Develops TEMCELL HS
• Stemedica Receives FDA Approval for Phase Iia Clinical Study for Traumatic Brain Injury
• PuRec Announces Plans to Produce MSCs/RECs
• Stemedica Enrolls into Phase I/IIa Clinical Study for Ischemic Stroke
• JCR Pharmaceuticals Receives Pricing Notification
• JCR Pharmaceuticals Awaits Approval for JR-031
• Stemedica Receives FDA's Approval for Phase Iia Clinical Study
• Mesoblast Announces Plans to Introduce Stem Cell Therapy Product
• Stemedica Receives Patent
• Stem Cell and Cancer Institute Receives IND approval
• Thermo Fisher Scientific Takes Over Life Technologies

7. FOCUS ON SELECT PLAYERS

8. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 47

• The United States (25)
• Canada (1)
• Japan (2)
• Europe (6)
• - Germany (2)  
• - The United Kingdom (1)
• - Rest of Europe (3)
• Asia-Pacific (Excluding Japan) (9)
• Latin America (1)
• Middle East (3)

For more information about this report visit http://www.researchandmarkets.com/research/2qzss5/mesenchymal_stem

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]